Kalkhoven E - Search Results

1

CBP and p300: HATs for different occasions.

Kalkhoven E. Kalkhoven E. Biochem Pharmacol. 2004 Sep 15;68(6):1145-55. doi: 10.1016/j.bcp.2004.03.045. Biochem Pharmacol. 2004. PMID: 15313412 Review.

2

A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

Vries RG, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E, Zantema A. Vries RG, et al. Among authors: kalkhoven e. EMBO J. 2001 Nov 1;20(21):6095-103. doi: 10.1093/emboj/20.21.6095. EMBO J. 2001. PMID: 11689449 Free PMC article.

3

The PHD type zinc finger is an integral part of the CBP acetyltransferase domain.

Kalkhoven E, Teunissen H, Houweling A, Verrijzer CP, Zantema A. Kalkhoven E, et al. Mol Cell Biol. 2002 Apr;22(7):1961-70. doi: 10.1128/mcb.22.7.1961-1970.2002. Mol Cell Biol. 2002. PMID: 11884585 Free PMC article.

4

Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.

Martens JH, Verlaan M, Kalkhoven E, Dorsman JC, Zantema A. Martens JH, et al. Among authors: kalkhoven e. Mol Cell Biol. 2002 Apr;22(8):2598-606. doi: 10.1128/mcb.22.8.2598-2606.2002. Mol Cell Biol. 2002. PMID: 11909954 Free PMC article.

5

Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.

Kalkhoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, Zantema A, Breuning MH, Hennekam RC, Peters DJ. Kalkhoven E, et al. Hum Mol Genet. 2003 Feb 15;12(4):441-50. doi: 10.1093/hmg/ddg039. Hum Mol Genet. 2003. PMID: 12566391

6

Cascade of distinct histone modifications during collagenase gene activation.

Martens JH, Verlaan M, Kalkhoven E, Zantema A. Martens JH, et al. Among authors: kalkhoven e. Mol Cell Biol. 2003 Mar;23(5):1808-16. doi: 10.1128/mcb.23.5.1808-1816.2003. Mol Cell Biol. 2003. PMID: 12588998 Free PMC article.

7

MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.

Kindle KB, Troke PJ, Collins HM, Matsuda S, Bossi D, Bellodi C, Kalkhoven E, Salomoni P, Pelicci PG, Minucci S, Heery DM. Kindle KB, et al. Among authors: kalkhoven e. Mol Cell Biol. 2005 Feb;25(3):988-1002. doi: 10.1128/MCB.25.3.988-1002.2005. Mol Cell Biol. 2005. PMID: 15657427 Free PMC article.

8

MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.

Collins HM, Kindle KB, Matsuda S, Ryan C, Troke PJF, Kalkhoven E, Heery DM. Collins HM, et al. Among authors: kalkhoven e. J Biol Chem. 2006 Jun 23;281(25):17124-17133. doi: 10.1074/jbc.M602633200. Epub 2006 Apr 13. J Biol Chem. 2006. PMID: 16613851

9

Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription.

Winkler GS, Mulder KW, Bardwell VJ, Kalkhoven E, Timmers HT. Winkler GS, et al. Among authors: kalkhoven e. EMBO J. 2006 Jul 12;25(13):3089-99. doi: 10.1038/sj.emboj.7601194. Epub 2006 Jun 15. EMBO J. 2006. PMID: 16778766 Free PMC article.

10

Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.

Jeninga EH, van Beekum O, van Dijk AD, Hamers N, Hendriks-Stegeman BI, Bonvin AM, Berger R, Kalkhoven E. Jeninga EH, et al. Among authors: kalkhoven e. Mol Endocrinol. 2007 May;21(5):1049-65. doi: 10.1210/me.2006-0485. Epub 2007 Feb 20. Mol Endocrinol. 2007. PMID: 17312272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results